FIELD: medicine.
SUBSTANCE: pharmaceutical preparation for treatment of hypercholesterolemia and hyperlipemia containing an amorphous active material in inert gas medium. There are disclosed stabilisation method of the pharmaceutical preparation containing pharmaceutical composition with the amorphous active material, stabilisation process of the pharmaceutical composition containing the amorphous active method, and stabilisation method of the amorphous active material. The amorphous active substance may represent amorphous calcium atorvastatin.
EFFECT: improved effectiveness.
25 cl, 3 ex, 4 tbl
Authors
Dates
2009-06-20—Published
2003-10-10—Filed